- Previous Close
78.42 - Open
76.98 - Bid 73.58 x --
- Ask 73.58 x --
- Day's Range
72.38 - 77.74 - 52 Week Range
70.96 - 86.09 - Volume
275,678 - Avg. Volume
230,257 - Market Cap (intraday)
36.389B - Beta (5Y Monthly) 0.77
- PE Ratio (TTM)
40.87 - EPS (TTM)
1.80 - Earnings Date --
- Forward Dividend & Yield 0.24 (0.31%)
- Ex-Dividend Date May 14, 2024
- 1y Target Est
--
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, grieshaber, MIVS instruments, scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
www.alcon.com25,599
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: ALCZ.XC
View MorePerformance Overview: ALCZ.XC
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ALCZ.XC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ALCZ.XC
View MoreValuation Measures
Market Cap
38.78B
Enterprise Value
41.68B
Trailing P/E
43.63
Forward P/E
27.55
PEG Ratio (5yr expected)
2.67
Price/Sales (ttm)
4.49
Price/Book (mrq)
2.05
Enterprise Value/Revenue
4.80
Enterprise Value/EBITDA
17.76
Financial Highlights
Profitability and Income Statement
Profit Margin
10.27%
Return on Assets (ttm)
2.85%
Return on Equity (ttm)
4.83%
Revenue (ttm)
9.91B
Net Income Avi to Common (ttm)
1.02B
Diluted EPS (ttm)
1.80
Balance Sheet and Cash Flow
Total Cash (mrq)
1.84B
Total Debt/Equity (mrq)
23.85%
Levered Free Cash Flow (ttm)
1.35B